FEATURED EDITORIAL
A poorly designed mRNA sequence can create ongoing difficulties during downstream clinical development and manufacture. Let's take a closer look at strategies and design software that you can employ.
- Designing Our Way Toward Circular RNA Medicines With AI
- Will Genome Modifications Define Next-Gen AAV Vectors?
- Formulation Is Key For Y-mAbs' Self-Assembling Antibody
- ADCs Unleashed: Navigating Development Hurdles In Targeted Cancer Therapy
- Protecting Intellectual Property In The Genomics Revolution
- PheWAS Is Your Friend
- Understanding The Impact Of An RMP On Patient Risks Using Relational Risk Analysis
FEATURED APPLICATION CONTENT
-
Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.
-
Raman spectroscopy has revolutionized manufacturing through real-time monitoring. Explore a system that enables a seamless calibration model transfer from small- to large-scale bioreactors to enhance scalability and efficiency.
-
Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.
-
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Discover how these approaches advance modern medicine and improve patient outcomes.
-
Delve into the intricate workflow employed for the discovery and characterization of monoclonal antibodies (mAbs) targeting the Delta spike protein.
-
Overcoming the limitations of current proximity inducers requires optimizing cooperativity. Learn how enhancing target affinity can lead to smaller, more effective therapeutics with better safety profiles.
-
Maximize your research potential by overcoming workflow bottlenecks. This piece explores flexible strategies for increasing throughput and integrating automation seamlessly into your laboratory operations.
-
Continuous processes enhance product quality, yield, and cost savings. Explore transitioning a fed-batch process to perfusion using a small batch bioreactor system to optimize cell culture conditions and comparing performances.
-
Discover how a company overcame cell generation challenges by using a system that achieves a seed ratio of 1:120 and saves four days in seed preparation time.
-
Efforts to enhance biopharmaceutical manufacturing focus on boosting production capacity sustainably and economically. Explore how optimizing processes with single-use solutions and monitoring leachables ensures product quality.
-
Discover the critical role of formulation buffer composition in stabilizing monoclonal antibodies during tangential flow filtration, a process involving ultrafiltration and diafiltration under high pressure and shear forces.
FEATURED NEWS HEADLINES
- Salipro Biotech And Daewoong Pharmaceutical Announce Collaboration Agreement To Advance Development Of Novel Therapeutics
- Silicogenix Partners With BioDuro To Accelerate Novel Drug Discovery For Complex Diseases
- China's Center For Drug Evaluation Accepts Merck KGaA, Darmstadt, Germany's Application For Marketing Authorization Of Pimicotinib For Treatment Of Tenosynovial Giant Cell Tumor
- Emulate Launches AVA Emulation System To Accelerate Drug Development With First-Of-Its-Kind High-Throughput Organ-Chip Platform
- AlphaMeld Corporation And VedTechBio Forge Strategic AI-Powered Drug Discovery Alliance To Transform Metabolic And Liver Disease Therapeutics
- CN Bio Introduces Cross-Species DILI Services To Enhance In Vitro To In Vivo Extrapolation During Preclinical Drug Development
- Bexorg Announces Research Collaboration With Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform To Enhance CNS Drug Development
- IonQ Speeds Quantum-Accelerated Drug Development Application With AstraZeneca, AWS, And NVIDIA
- MIT Releases Breakthrough Protein-Binding Affinity Model, Expanding Role Of AI In Drug Discovery
- Juvenescence Acquires AI Drug Discovery Company Ro5 To Boost R&D Capabilities And Drive Pipeline Of Medicines To Extend Healthy Lifespan
ARCHIVED NEWSLETTER
- 06.11.25 -- From Complexity To Efficiency: The Future Of Drug Development
- 06.10.25 -- Your Go-To Guide For CNS Drug Development
- 06.10.25 -- Understanding The Impact Of An RMP On Patient Risks Using Relational Risk Analysis
- 06.03.25 -- Designing The Next Wave Of T Cell Engagers
- 05.28.25 -- Efficient Biologics Stability Characterization In Regulated Environments